Medytox shares soar after it enters three-party botox settlement in US
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
In December last year, the ITC ordered a 21-month import ban after finding Daewoong stole trade secrets for a manufacturing process.
Under the terms of the settlement agreements released to the U.S. Securities and Exchange Commission (SEC) last weekend, Evolus will issue 6.76 million common stocks worth 53.5 billion won ($48.3 million), or a 16.7 percent stake, to Medytox, while paying the settlement money of $35 million to Medytox and Allergan over the next two years. Medytox and Allergan will release all claims against Evolus related to the alleged misappropriation of Medytox's trade secrets and grant a license to Evolus to continue to commercialize Jeuveau, the U.S. brand name of Daewoong’s botox products.
Shares of Medytox soared by the daily limit of 30 percent to 197,600 won. Those of Daewoong also gained 14.3 percent to close Monday at 155,500 won upon the resolution of the legal issue and marketing uncertainties in the U.S.
Daewoong Pharmaceutical invested 48 billion won in Evolus after the ITC’s preliminary ruling last year to acquire 3.07 million convertible bond issues of Evolus, placing the U.S. company under the influence of both rivaling Korean companies.
The settlement would close all legal action taken by Medytox against Evolus in California and invalidates the ITC ruling. After its legal fight with Daewoong that began in 2016, Medytox lost its market leadership to another rival Hugel in Korea, while facing license revocation of its key products by health authorities for alleged criminal wrongdoing.
The settlement does not affect ongoing legal fights between Medytox and Daewoong in Korea.
Daewoong Pharmaceutical said it has not agreed to the three-party settlement, but will completely address business risk in the U.S. by speeding up market penetration based on its advanced quality and technology.
[ⓒ Maeil Business Newspaper & mk.co.kr, All rights reserved]
Copyright © 매일경제 & mk.co.kr. 무단 전재, 재배포 및 AI학습 이용 금지
- S. Korea’s Feb. 1-20 exports up 17% on brisk chip, auto demand - Pulse by Maeil Business News Korea
- GS Caltex mulls doubling bond issue on heated appetite from investors - Pulse by Maeil Business News Korea
- KOSE joins Korea’s tanker hot streak with new orders of $489 mn - Pulse by Maeil Business News Korea
- Korean stocks with interest in TMON rally after pre-IPO capital scheme - Pulse by Maeil Business News Korea
- Speculations arise that LG Elec may have put rollable phone project on hold - Pulse by Maeil Business News Korea
- 강경준, 상간남 피소…사랑꾼 이미지 타격 [MK픽] - 스타투데이
- 분당 시범, 일산 강촌·백마 “대장주는 우리”
- 권지용, 카이스트 교수 되다...26년까지 기계공학과 초빙교수 임용 (공식) - MK스포츠
- 이찬원, 이태원 참사에 "노래 못해요" 했다가 봉변 당했다 - 스타투데이
- 양희은·양희경 자매, 오늘(4일) 모친상 - 스타투데이